Neurotrophic action of insulin-like growth factor-I in the inner ear;Acciones neurotróficas del factor de crecimiento similar a la insulina de tipo I en el oído interno

Revista de Neurologia

Volumn 45, Issue 4, 2007, Pages 245-250

  Rodriguez de La Rosa L ^a   Contreras Rodriguez J ^a,b   Cediel Algovia, R ^a,b   Leon Y ^a   Sanchez Calderon H ^a   Murillo Cuesta, S ^a   Riquelme Galiana, R ^a   De Diego Sastre, J I ^c   Prim Espada, M P ^c   Varela Nieto, Isabel ^a,d  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^d INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

Author keywords

Auditory function; Brainstem auditory evoked potentials; Insulin like growth factor I; Neurosensory hypoacusis; Otic development; Phenotype genotype relationship

Indexed keywords

SOMATOMEDIN C;

APOPTOSIS; AUDITORY SYSTEM; CELL DIFFERENTIATION; CELL PROLIFERATION; DRUG POTENCY; EMBRYO DEVELOPMENT; EVOKED BRAIN STEM AUDITORY RESPONSE; HYPOACUSIS; INNER EAR; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; REVIEW;

EID: 37349041074     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4504.2007099     Document Type: Review

References (78)

1. Swanson GJ, Howard M, Lewis J. Epithelial autonomy in the development of the inner ear of a bird embryo. Dev Biol. 1990; 137: 243-57.
2. Sanz C, León Y, Canon S, Álvarez L, Giráldez F, Varela-Nieto I. Pattern of expression of the jun family of transcription factors during the early development of the inner ear: implications in apoptosis. J Cell Sci 1999; 112: 3967-74.
3. Fekete DM, Wu DK. Revisiting cell fate specification in the inner ear. Curr Opin Neurobiol. 2002; 12: 35-42.
4. Hemond SG, Morest DK. Ganglion formation from the otic placode and the otic crest in the chick embryo: mitosis, migration, and the basal lamina. Anat Embryol (Berl) 1991; 184: 1-13.
5. Rubel EW, Fritzsch B. Auditory system development: primary auditory neurons and their targets. Annu Rev Neurosci 2002; 25: 51-101.
6. Alsina B, Giraldez F, Varela-Nieto I. Growth factors and early development of otic neurons: interactions between intrinsic and extrinsic signals. Curr Top Dev Biol 2003; 57: 177-206.
7. Efstratiadis A. Genetics of mouse growth. Int J Dev Biol 1998; 42: 955-76.
8. Nakae J, Kido Y, Accili D. Distinct and overlapping functions of insulin and IGF-I receptors. Endocr Rev 2001; 22: 818-35.
9. Varela-Nieto I, De la Rosa EJ, Valenciano AI, Leon Y. Cell death in the nervous system: lessons from insulin and insulin-like growth factors. Mol Neurobiol 2003; 28: 23-50.
10. Yakar S, Sun H, Zhao H, Pennisi P, Toyoshima Y, Setser J, et al. Metabolic effects of IGF-I deficiency: lessons from mouse models. Pediatr Endocrinol Rev 2005; 3: 11-9.
11. Kirkwood TB. Genes that shape the course of ageing. Trends Endocrinol Metab 2003; 14: 345-7.
12. Hamilton B, Dong Y, Shindo M, Liu W, Odell I, Ruvkun G, et al. A systematic RNAi screen for longevity genes in C. elegans. Genes Dev 2005; 19: 1544-55.
13. Hernández-Sánchez C, Mansilla A, De la Rosa EJ, De Pablo F. Proinsulin in development: New roles for an ancient prohormone. Diabetologia 2006; 49: 1142-50.
14. Bateman JM, McNeill H. Insulin/IGF signalling in neurogenesis. Cell Mol Life Sci 2006; 63: 1701-5.
15. Ye P, D'Ercole AJ. Insulin-like growth factor actions during development of neural stem cells and progenitors in the central nervous system. J Neurosci Res 2006; 83: 1-6.
16. Dore S, Kar S, Quirion R. Rediscovering an old friend, IGF-I: potential use in the treatment of neurodegenerative diseases. Trends Neurosci 1997; 20: 326-31.
17. Cardona-Gómez GP, Méndez P, DonCarlos LL, Azcoitia I, García-Segura LM. Interactions of estrogens and insulin-like growth factor-I in the brain: implications for neuroprotection. Brain Res Brain Res Rev 2001; 37: 320-34.
18. Savage MA, Camacho-Hubner C, Dunger DB, Ranke MB, Ross RJ, Rosenfeld RG. Is there a medical need to explore the clinical use of insulin-like growth factor I. Growth Horm. IGF Res 2001; 11 (Suppl): S65-9.
19. Méndez P, Cardona-Gómez GP, García-Segura LM. Interactions of insulin-like growth factor-I and estrogen in the brain. Adv Exp Med Biol 2005; 567: 285-303.
20. Carro E, Spuch C, Trejo JL, Antequera D, Torres-Alemán I. Choroid plexus megalin is involved in neuroprotection by serum insulin-like growth factor I. J Neurosci 2005; 25: 10884-93.
21. Carro E, Trejo JL, Spuch C, Bohl D, Heard JM, Torres-Alemán I. Blockade of the insulin-like growth factor I receptor in the choroid plexus originates Alzheimer's-like neuropathology in rodents: new cues into the human disease? Neurobiol Aging 2006; 27: 1618-31.
22. León Y, Vázquez E, Sanz C, Vega JA, Mato JM, Giráldez F, et al. Insulin-like growth factor-I regulates cell proliferation in the developing inner ear, activating glycosyl- phosphatidylinositol hydrolysis and Fos expression. Endocrinology 1995; 136: 3494-503.
23. Camarero G, León Y, Gorospe I, De Pablo F, Alsina B, Giráldez F, et al. Insulin-like growth factor 1 is required for survival of transit-amplifying neuroblasts and differentiation of otic neurons. Dev Biol 2003; 262: 242-53.
24. Hernández-Sánchez C, Bartulos O, De Pablo F. Proinsulin: much more than a hormone precursor in development. Rev Endocr Metab Disord 2005; 6: 211-6.
25. Frago LM, León Y, De la Rosa EJ, Gómez-Muñoz A, Varela-Nieto I. Nerve growth factor and ceramides modulate cell death in the early developing inner ear. J Cell Sci 1998; 111: 549-56.
26. Frago LM, Canon S, De la Rosa EJ, León Y, Varela-Nieto I. Programmed cell death in the developing inner ear is balanced by nerve growth factor and insulin-like growth factor I. J Cell Sci 2003; 116: 475-86.
27. León Y, Sanz C, Giráldez F, Varela-Nieto I. Induction of cell growth by insulin and insulin-like growth factor-I is associated with Jun expression in the otic vesicle. J Comp Neurol 1998; 398: 323-32.
28. Sanz C, León Y, Troppmair J, Rapp UR, Varela-Nieto I. Strict regulation of c-Raf kinase levels is required for early organogenesis of the vertebrate inner ear. Oncogene 1999; 18: 429-37.
29. Pimentel B, Sanz C, Varela-Nieto I, Rapp UR, De Pablo F, De la Rosa EJ. c-Raf regulates cell survival and retinal ganglion cell morphogenesis during neurogenesis. J Neurosci 2000; 20: 3254-62.
30. Balboa MA, Varela-Nieto I, Killermann Lucas K, Dennis EA. Expression and function of phospholipase A(2) in brain. FEBS Lett 2002; 531: 12-7.
31. Frago LM, Sánchez-Calderón H, Varela-Nieto I, León Y. The ceramide/ ceramide-1-phosphate biostat in development. In Albi E, ed. Sphingolipids and cell function. Kerala, India: A. Gayathri; 2006.
32. Camarero G, Avendaño C, Fernández-Moreno C, Villar A, Contreras J, De Pablo F, et al. Delayed inner ear maturation and neuronal loss in posnatal Igf-1-deficient mice. J Neurosci 2001; 21: 7630-41.
33. Varela-Nieto I, Morales-García JA, Vigil P, Díaz-Casares A, Gorospe I, Sánchez-Galiano S, et al. Trophic effects of insulin-like growth factor-I (IGF-I) in the inner ear. Hear Res 2004; 196: 19-25.
34. Cho Y, Gong TW, Stover T, Lomax MI, Altschuler RA. Gene expression profiles of the rat cochlea, cochlear nucleus, and inferior colliculus. J Assoc Res Otolaryngol 2002; 3: 54-67.
35. Resendes BL, Robertson NG, Szustakowski JD, Resendes RJ, Weng Z, Morton CC. Gene discovery in the auditory system: characterization of additional cochlear-expressed sequences. J Assoc Res Otolaryngol 2002; 3: 45-53.
36. Li Y, Xiang J, Duan C. Insulin-like growth factor-binding protein-3 plays an important role in regulating pharyngeal skeleton and inner ear formation and differentiation. J Biol Chem 2005; 280: 3613-20.
37. Sun LY, D'Ercole AJ. Insulin-like growth factor-I stimulates histone H3 and H4 acetylation in the brain in vivo. Endocrinology 2006; 147: 5480-90.
38. Powell-Braxton L, Hollingshead P, Warburton C, Dowd M, Pitts-Meek S, Dalton D, et al. IGF-I is required for normal embryonic growth in mice. Genes Dev 1993; 7: 2609-17.
39. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 1993; 75: 59-72.
40. Liu JL, Grinberg A, Westphal H, Sauer B, Accili D, Karas M, et al. Insulin-like growth factor-I affects perinatal lethality and posnatal development in a gene dosage-dependent manner: manipulation using the Cre/ loxP system in transgenic mice. Mol Endocrinol 1998; 12: 1452-62.
41. Vicario-Abejón C, Yusta-Boyo MJ, Fernández-Moreno C, De Pablo F. Locally born olfactory bulb stem cells proliferate in response to insulin-related factors and require endogenous insulin-like growth factor-I for differentiation into neurons and glia. J Neurosci 2003; 23: 895-906.
42. Vicario-Abejón C, Fernández-Moreno C, Pichel JG, De Pablo F. Mice lacking IGF-I and LIF have motoneuron deficits in brain stem nuclei. Neuroreport 2004; 15: 2769-72.
43. Moerth C, Schneider MR, Renner-Mueller I, Blutke A, Elmlinger MW, Erben RG, et al. Posnatally elevated levels of insulin-like growth factor-II (IGF-II) fail to rescue the dwarfism of IGF-I deficient mice except kidney weight. Endocrinology 2006; 148: 441-51.
44. Carson MJ, Behringer RR, Brinster RL, McMorris FA. Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice. Neuron 1993; 10: 729-40.
45. Beck KD, Powell-Braxton L, Widmer HR, Valverde J, Hefti F. Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons. Neuron 1995; 14: 717-30.
46. Ye P, Carson J, D'Ercole AJ. In vivo actions of insulin-like growth factor-I (IGF-I) on brain myelination: studies of IGF-I and IGF binding protein-1 (IGFBP-1) transgenic mice. J Neurosci 1995; 15: 7344-56.
47. Gao WQ, Shinsky N, Ingle G, Beck K, Elias KA, Powell-Braxton L. IGF-I deficient mice show reduced peripheral nerve conduction velocities and decreased axonal diameters and respond to exogenous IGF-I treatment. J Neurobiol 1999; 39: 142-52.
48. Hodge RD, D'Ercole AJ, O'Kusky JR. Increased expression of insulin-like growth factor-I (IGF-I) during embryonic development produces neocortical overgrowth with differentially greater effects on specific cytoarchitectonic areas and cortical layers. Brain Res Dev Brain Res 2005; 154: 227-37.
49. Camarero G, Villar MA, Contreras J, Fernández-Moreno C, Pichel JG, Avendaño C, et al. Cochlear abnormalities in insulin-like growth factor-1 mouse mutants. Hear Res 2002; 170: 2-11.
50. Burns JL, Hassan AB. Cell survival and proliferation are modified by insulin-like growth factor 2 between days 9 and 10 of mouse gestation. Development 2001; 128: 3819-30.
51. Cediel R, Riquelme R, Contreras J, Díaz A, Varela-Nieto I. Sensori-neural hearing loss in insulin-like growth factor I-null mice: a new model of human deafness. Eur J Neurosci 2006; 23: 587-90.
52. Oesterle EC, Tsue TT, Rubel EW. Induction of cell proliferation in avian inner ear sensory epithelia by insulin-like growth factor-I and insulin. J Comp Neurol 1997; 380: 262-74.
53. Sokolowski BH. Quantitative analysis of long-term survival and neuritogenesis in vitro: cochleovestibular ganglion of the chick embryo in BDNF, NT-3, NT-4/5, and insulin. Exp Neurol 1997; 145: 1-15.
54. Kuntz AL, Oesterle EC. Transforming growth factor-alpha with insulin induces proliferation in rat utricular extrasensory epithelia. Otolaryngol Head Neck Surg 1998; 118: 816-24.
55. Staecker H, Van de Water TR. Factors controlling hair-cell regeneration/ repair in the inner ear. Curr Opin Neurobiol 1998; 8: 480-7.
56. Romand R, Chardin S. Effects of growth factors on the hair cells after ototoxic treatment of the neonatal mammalian cochlea in vitro. Brain Res 1999; 825: 46-58.
57. Duan M, Agerman K, Ernfors P, Canlon B. Complementary roles of neurotrophin 3 and a N-methyl-D-aspartate antagonist in the protection of noise and aminoglycoside-induced ototoxicity. Proc Natl Acad Sci U S A 2000; 97: 7597-602.
58. Stacey DJ, McLean WG. Cytoskeletal protein mRNA expression in the chick utricle after treatment in vitro with aminoglycoside antibiotics: effects of insulin, iron chelators and cyclic nucleotides. Brain Res 2000; 871: 319-32.
59. Kopke RD, Jackson RL, Li G, Rasmussen MD, Hoffer ME, Frenz DA, et al. Growth factor treatment enhances vestibular hair cell renewal and results in improved vestibular function. Proc Natl Acad Sci U S A 2001; 98: 5886-91.
60. Kanzaki S, Stover T, Kawamoto K, Prieskorn DM, Altschuler RA, Miller JM, et al. Glial cell line-derived neurotrophic factor and chronic electrical stimulation prevent VIII cranial nerve degeneration following denervation. J Comp Neurol 2002; 454: 350-60.
61. Malgrange B, Rigo JM, Coucke P, Thiry M, Hans G, Nguyen L, et al. Identification of factors that maintain mammalian outer hair cells in adult organ of Corti explants. Hear Res 2002; 170: 48-58.
62. Woods KA, Camacho-Hubner C, Savage MO, Clark AJ. Intrauterine growth retardation and posnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl J Med 1996; 335: 1363-7.
63. Walenkamp MJ, Karperien M, Pereira AM, Hilhorst-Hofstee Y, Van Doorn J, Chen JW, et al. Homozygous and heterozygous expression of a novel insulin-like growth factor-I mutation. J Clin Endocrinol Metab 2005; 90: 2855-64.
64. Walenkamp MJ, Wit JM. Genetic disorders in the growth hormone -insulin-like growth factor-I axis. Horm Res 2006; 66: 221-30.
65. Cheng CM, Joncas G, Reinhardt RR, Farrer R, Quarles R, Janssen J, et al. Biochemical and morphometric analyses show that myelination in the insulin-like growth factor 1 null brain is proportionate to its neuronal composition. J Neurosci 1998; 18: 5673-81.
66. Ye P, Li L, Lund PK, D'Ercole AJ. Deficient expression of insulin receptor substrate-1 (IRS-1) fails to block insulin-like growth factor-I (IGF-I) stimulation of brain growth and myelination. Brain Res Dev Brain Res 2002; 136: 111-21
67. Ye P, Li L, Richards RG, DiAugustine RP, D'Ercole AJ. Myelination is altered in insulin-like growth factor-I null mutant mice. J Neurosci 2002; 22: 6041-51.
68. Sharland M, Burch M, McKenna WM, Paton MA. A clinical study of Noonan syndrome. Arch Dis Child 1992; 67: 178-83.
69. Barrenas M, Landin-Wilhelmsen K, Hanson C. Ear and hearing in relation to genotype and growth in Turner syndrome. Hear Res 2000; 144: 21-8.
70. Bonapace G, Concolino D, Formicola S, Strisciuglio P. A novel mutation in a patient with insulin-like growth factor 1 (IGF1) deficiency. J Med Genet 2003; 40: 913-7.
71. Noonan JA, Raaijmakers R, Hall BD. Adult height in Noonan syndrome. Am J Med Genet A 2003; 123: 68-71.
72. Barrenas ML, Bratthall A, Dahlgren J. The association between short stature and sensorineural hearing loss. Hear Res 2005; 205: 123-30.
73. Atar O, Avraham KB. Therapeutics of hearing loss: expectations vs reality. Drug Discov Today 2005; 10: 1323-30.
74. Holley MC. Keynote review: The auditory system, hearing loss and potential targets for drug development. Drug Discov Today 2005; 10: 1269-82.
75. Kawamoto K, Ishimoto S, Minoda R, Brough DE, Raphael Y. Math1 gene transfer generates new cochlear hair cells in mature guinea pigs in vivo. J Neurosci 2003; 23: 4395-400.
76. Izumikawa M, Minoda R, Kawamoto K, Abrashkin KA, Swiderski DL, Dolan DF, et al. Auditory hair cell replacement and hearing improvement by Atoh1 gene therapy in deaf mammals. Nat Med 2005; 11: 271-6.
77. Li H, Corrales CE, Edge A, Heller S. Stem cells as therapy for hearing loss. Trends Mol Med 2004; 10: 309-15.
78. Rivolta MN, Li H, Heller S. Generation of inner ear cell types from embryonic stem cells. Methods Mol Biol 2006; 330: 71-92.